Company page
Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc. is a public company traded under the ticker AXSM in the American market. The company has a market capitalization of approximately $12.89 billion. Axsome focuses on developing innovative therapies for central nervous system disorders.
- Ticker
- AXSM:NASDAQ
- Asset type
- Stock
- Market cap
- $12.89B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD